東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Neuroprotective agents." ]

切換: 標籤 | MARC模式 | ISBD

Nicotinic acetylcholine receptor sig...

Akaike, Akinori.

FindBook

Google Book

Amazon

博客來

Nicotinic acetylcholine receptor signaling in neuroprotection

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Nicotinic acetylcholine receptor signaling in neuroprotection/ edited by Akinori Akaike, Shun Shimohama, Yoshimi Misu.
其他作者:	Akaike, Akinori.
出版者:	Singapore :Springer Singapore : : 2018.,
面頁冊數:	x, 191 p. :ill. (some col.), digital ;24 cm.
內容註:	1.Overview -- 2.In vivo imaging of nicotinic acetylcholine receptors in the central nervous system -- 3.A new aspect of cholinergic transmission in the central nervous system -- 4.Nicotinic acetylcholine receptor signaling: roles in neuroprotection -- 5.Regulation by nicotinic acetylcholine receptors of microglial glutamate transporters: role of microglia in neuroprotection -- 6.Shati/Nat8l and N-acetylaspartate (NAA) have important roles in regulating nicotinic acetylcholine receptors in neuronal and psychiatric diseases in animal models and humans -- 7.Nicotinic acetylcholine receptors in regulation of pathology of cerebrovascular disorders -- 8.Roles of nicotinic acetylcholine receptors in the pathology and treatment of Alzheimer's and Parkinson's diseases -- 9.SAK3-induced neuroprotection is mediated by nicotinic acetylcholine receptors -- 10.Removal of blood amyloid as a therapeutic strategy for Alzheimer's disease: the influence of smoking and nicotine.
Contained By:	Springer eBooks
標題:	Nicotinic receptors. -
電子資源:	http://dx.doi.org/10.1007/978-981-10-8488-1
ISBN:	9789811084881

Nicotinic acetylcholine receptor signaling in neuroprotection
Nicotinic acetylcholine receptor signaling in neuroprotection[electronic resource] /edited by Akinori Akaike, Shun Shimohama, Yoshimi Misu. - Singapore :Springer Singapore :2018. - x, 191 p. :ill. (some col.), digital ;24 cm.

1.Overview -- 2.In vivo imaging of nicotinic acetylcholine receptors in the central nervous system -- 3.A new aspect of cholinergic transmission in the central nervous system -- 4.Nicotinic acetylcholine receptor signaling: roles in neuroprotection -- 5.Regulation by nicotinic acetylcholine receptors of microglial glutamate transporters: role of microglia in neuroprotection -- 6.Shati/Nat8l and N-acetylaspartate (NAA) have important roles in regulating nicotinic acetylcholine receptors in neuronal and psychiatric diseases in animal models and humans -- 7.Nicotinic acetylcholine receptors in regulation of pathology of cerebrovascular disorders -- 8.Roles of nicotinic acetylcholine receptors in the pathology and treatment of Alzheimer's and Parkinson's diseases -- 9.SAK3-induced neuroprotection is mediated by nicotinic acetylcholine receptors -- 10.Removal of blood amyloid as a therapeutic strategy for Alzheimer's disease: the influence of smoking and nicotine.

Open access.

This open access book presents the roles and mechanisms of signal transduction triggered by nicotinic acetylcholine receptors (nAChRs) stimulation in neuroprotection against toxic effects of risk factors of neurodegenerative diseases. Accumulating evidence suggests that nAChRs in the CNS play important roles not only in excitatory neurotransmission but also in neuronal survival and related functions. Neuroprotection mediated by nAChRs in neurodegenerative diseases such as Alzheimer's disease is the major topic of this book. In response to rapidly evolving areas in clinical and laboratory neuropharmacology and neurochemistry, this volume provides in-depth coverage of neuroprotection in basic research and future developments in the clinical application of effective neuroprotective strategies in neurodegenerative diseases. This work appeals to both basic and clinical researchers in several fields, such as neuroscience, neurology, and pharmacology. This book is published with open access under a CC BY 4.0 license.

ISBN: 9789811084881

Standard No.: 10.1007/978-981-10-8488-1doiSubjects--Topical Terms:

2111358
Nicotinic receptors.

LC Class. No.: QP364.7 / .N536 2018

Dewey Class. No.: 612.8042

Nicotinic acetylcholine receptor signaling in neuroprotection
LDR:03038nmm a2200325 a 4500 001 2136405
003 DE-He213
005 20180830170614.0
006 m d
007 cr nn 008maaau
008 181117s2018 si s 0 eng d
020 $a 9789811084881 $q (electronic bk.)
020 $a 9789811084874 $q (paper)
024 7 $a 10.1007/978-981-10-8488-1 $2 doi
035 $a 978-981-10-8488-1
040 $a GP $c GP
041 0 $a eng
050 4 $a QP364.7 $b .N536 2018
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
082 0 4 $a 612.8042 $2 23
090 $a QP364.7 $b .N662 2018
245 0 0 $a Nicotinic acetylcholine receptor signaling in neuroprotection $h [electronic resource] / $c edited by Akinori Akaike, Shun Shimohama, Yoshimi Misu.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2018.
300 $a x, 191 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a 1.Overview -- 2.In vivo imaging of nicotinic acetylcholine receptors in the central nervous system -- 3.A new aspect of cholinergic transmission in the central nervous system -- 4.Nicotinic acetylcholine receptor signaling: roles in neuroprotection -- 5.Regulation by nicotinic acetylcholine receptors of microglial glutamate transporters: role of microglia in neuroprotection -- 6.Shati/Nat8l and N-acetylaspartate (NAA) have important roles in regulating nicotinic acetylcholine receptors in neuronal and psychiatric diseases in animal models and humans -- 7.Nicotinic acetylcholine receptors in regulation of pathology of cerebrovascular disorders -- 8.Roles of nicotinic acetylcholine receptors in the pathology and treatment of Alzheimer's and Parkinson's diseases -- 9.SAK3-induced neuroprotection is mediated by nicotinic acetylcholine receptors -- 10.Removal of blood amyloid as a therapeutic strategy for Alzheimer's disease: the influence of smoking and nicotine.
506 $a Open access.
520 $a This open access book presents the roles and mechanisms of signal transduction triggered by nicotinic acetylcholine receptors (nAChRs) stimulation in neuroprotection against toxic effects of risk factors of neurodegenerative diseases. Accumulating evidence suggests that nAChRs in the CNS play important roles not only in excitatory neurotransmission but also in neuronal survival and related functions. Neuroprotection mediated by nAChRs in neurodegenerative diseases such as Alzheimer's disease is the major topic of this book. In response to rapidly evolving areas in clinical and laboratory neuropharmacology and neurochemistry, this volume provides in-depth coverage of neuroprotection in basic research and future developments in the clinical application of effective neuroprotective strategies in neurodegenerative diseases. This work appeals to both basic and clinical researchers in several fields, such as neuroscience, neurology, and pharmacology. This book is published with open access under a CC BY 4.0 license.
650 0 $a Nicotinic receptors. $3 2111358
650 0 $a Cellular signal transduction. $3 600648
650 0 $a Neuroprotective agents. $3 900423
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Neurosciences. $3 588700
650 2 4 $a Neurology. $3 588698
650 2 4 $a Pharmacology/Toxicology. $3 890953
700 1 $a Akaike, Akinori. $3 3307757
700 1 $a Shimohama, Shun. $3 3307758
700 1 $a Misu, Yoshimi. $3 3307759
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-8488-1
950 $a Biomedical and Life Sciences (Springer-11642)